On Tuesday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) opened lower -1.46% from the last session, before settling in for the closing price of $6.86. Price fluctuations for BCRX have ranged from $6.00 to $11.31 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 14.52%. Company’s average yearly earnings per share was noted 128.94% at the time writing. With a float of $195.75 million, this company’s outstanding shares have now reached $210.52 million.
Biocryst Pharmaceuticals Inc (BCRX) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Biocryst Pharmaceuticals Inc is 7.02%, while institutional ownership is 92.87%. The most recent insider transaction that took place on Aug 13 ’25, was worth 595,868. In this transaction Director of this company sold 70,000 shares at a rate of $8.51, taking the stock ownership to the 65,352 shares. Before that another transaction happened on Aug 13 ’25, when Company’s Director proposed sale 70,000 for $8.51, making the entire transaction worth $595,871.
Biocryst Pharmaceuticals Inc (BCRX) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.13 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.06) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.12 per share during the current fiscal year.
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) Trading Performance Indicators
Check out the current performance indicators for Biocryst Pharmaceuticals Inc (BCRX). In the past quarter, the stock posted a quick ratio of 2.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.41. Likewise, its price to free cash flow for the trailing twelve months is 93.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.05, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.18 in one year’s time.
Technical Analysis of Biocryst Pharmaceuticals Inc (BCRX)
The latest stats from [Biocryst Pharmaceuticals Inc, BCRX] show that its last 5-days average volume of 6.87 million was superior to 4.02 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 40.16%.
During the past 100 days, Biocryst Pharmaceuticals Inc’s (BCRX) raw stochastic average was set at 17.02%, which indicates a significant decrease from 31.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.27 in the past 14 days, which was higher than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.53, while its 200-day Moving Average is $8.43. Now, the first resistance to watch is $6.93. This is followed by the second major resistance level at $7.10. The third major resistance level sits at $7.31. If the price goes on to break the first support level at $6.55, it is likely to go to the next support level at $6.34. Assuming the price breaks the second support level, the third support level stands at $6.17.
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) Key Stats
There are currently 209,920K shares outstanding in the company with a market cap of 1.44 billion. Presently, the company’s annual sales total 450,710 K according to its annual income of -88,880 K. Last quarter, the company’s sales amounted to 163,350 K and its income totaled 5,090 K.
